These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 18971095

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH, Gaglia MA, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, Lemesle G, Torguson R, Kineshige K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):491-5. PubMed ID: 19195508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Zakliczynski M, Lekston A, Osuch M, Swierad M, Nadziakiewicz P, Przybylski R, Zembala M.
    Transplant Proc; 2007 Nov 15; 39(9):2859-61. PubMed ID: 18022002
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
    Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.
    Chin Med J (Engl); 2009 Mar 20; 122(6):643-7. PubMed ID: 19323927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2029-36. PubMed ID: 18021868
    [Abstract] [Full Text] [Related]

  • 13. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D, Di Salvo ME, Capranzano P, Seminara D, Caggegi A, Barrano G, Tamburino C.
    Minerva Cardioangiol; 2009 Feb 20; 57(1):1-6. PubMed ID: 19202514
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, Park SW, Seung KB, Gwon HC, Jeong MH, Jang Y, Kim HS, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ, Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators.
    Circulation; 2009 Aug 04; 120(5):400-7. PubMed ID: 19620506
    [Abstract] [Full Text] [Related]

  • 15. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Slottow TL, Xue Z, Torguson R, Kaneshige K, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):496-500. PubMed ID: 19195509
    [Abstract] [Full Text] [Related]

  • 16. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P, Normand SL, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L.
    Circulation; 2008 Nov 25; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [Abstract] [Full Text] [Related]

  • 17. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 18. Repeat coronary revascularization procedures after successful bare-metal or drug-eluting stent implantation.
    Yock CA, Isbill JM, King SB, Hlatky MA.
    J Invasive Cardiol; 2010 Jan 20; 22(1):27-33. PubMed ID: 20048396
    [Abstract] [Full Text] [Related]

  • 19. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Lekston A, Zakliczyński M, Gasior M, Osuch M, Wilczek K, Kalarus Z, Osadnik T, Poloński L, Zembala M.
    Kardiol Pol; 2010 Feb 20; 68(2):131-4. PubMed ID: 20301021
    [Abstract] [Full Text] [Related]

  • 20. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events.
    Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum A, Huang W, Gore JM, Global Registry of Acute Coronary Events (GRACE) Investigators.
    Eur Heart J; 2009 Feb 20; 30(3):321-9. PubMed ID: 19147604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.